Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two regimens of lithium prophylaxis and renal function.

A Muir1, R Davidson, T Silverstone

  • 1Academic Unit of Human Psychopharmacology, Medical College of St Bartholomew's Hospital, London, United Kingdom.

Acta Psychiatrica Scandinavica
|December 1, 1989
PubMed
Summary

This study compared daily lithium carbonate versus twice-daily lithium citrate in bipolar patients. Both lithium regimens demonstrated similar effects on clinical outcomes and renal function over 12 months.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design of the shattered pellet injection system for ASDEX Upgrade.

The Review of scientific instruments·2023
Same author

Scintillation light detection in the 6-m drift-length ProtoDUNE Dual Phase liquid argon TPC.

The European physical journal. C, Particles and fields·2022
Same author

Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment: DUNE Collaboration.

The European physical journal. C, Particles and fields·2021
Same author

Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus.

Molecular genetics and metabolism·2021
Same author

Development and internal validation of clinical prediction models for outcomes of complicated intra-abdominal infection.

The British journal of surgery·2021
Same author

First Results from the DEAP-3600 Dark Matter Search with Argon at SNOLAB.

Physical review letters·2018

Area of Science:

  • Pharmacology
  • Nephrology
  • Psychiatry

Background:

  • Lithium is a cornerstone mood stabilizer for bipolar disorder.
  • Different lithium formulations possess distinct pharmacokinetic profiles.
  • Understanding the long-term renal effects of various lithium regimens is crucial for patient management.

Purpose of the Study:

  • To compare the impact of once-daily lithium carbonate (Priadal) versus twice-daily lithium citrate (Litarex) on renal function in bipolar patients.
  • To assess the relative clinical outcomes and side effects of these two lithium prophylaxis regimens.

Main Methods:

  • A 12-month, double-blind, randomized controlled trial involving 25 bipolar patients in remission.
  • Patients were stabilized on lithium and then randomly assigned to either once-daily lithium carbonate or twice-daily lithium citrate.

Related Experiment Videos

  • Renal function was comprehensively assessed at baseline, 6-9 months, and 12 months.

    • Main Results:

    • No statistically significant differences were observed in clinical outcomes between the two lithium regimens.
    • Patient-reported side effects did not differ significantly between the once-daily and twice-daily lithium groups.
    • Comprehensive renal function tests revealed no significant differences between the lithium carbonate and lithium citrate regimens over the study period.

    Conclusions:

    • Once-daily lithium carbonate and twice-daily lithium citrate exhibit comparable efficacy and safety profiles in maintaining bipolar disorder remission.
    • Both lithium regimens appear to have similar long-term effects on renal function in stabilized bipolar patients.
    • The choice between these lithium formulations may not significantly impact renal health in the studied population.